AAV9–based gene therapy(Virovek/Sanofi)

VIVEK AGGARWAL

Australia

FDA Approves First Gene Therapy, Vijuvek, for Rare Skin Disease Epidermolysis Bullosa

Krystal Biotech's VYJUVEK Drives Revenue Growth; Expands Pipeline

FDA Approves Vyjuvek: Breakthrough Topical Gene Therapy for Dystrophic Epidermolysis Bullosa